US Drug Recall Register

Is Pine recalled?

Yes — there is an active recall. 82 ongoing FDA recalls mention Pine (685 total). Check the affected lots below.

Recalls are matched by product description. A recall usually affects specific lots, not every package of Pine. “Active” means an FDA recall is still ongoing; “closed” means it was terminated or completed.

Class II · Moderate risk Terminated

Mirtazapine Tablets

Reason Presence of Foreign Tablets/Capsules; possibility of Glipizide 10 mg tablet in bottle

Mylan Pharmaceuticals Inc. D-0492-2017
Class II · Moderate risk Ongoing

Quad Mix

Reason Lack of Assurance of Sterility

Tri-Coast Pharmacy D-0286-2017
Class II · Moderate risk Ongoing

Quad Mix

Reason Lack of Assurance of Sterility

Tri-Coast Pharmacy D-0285-2017
Class II · Moderate risk Ongoing

Quad Mix

Reason Lack of Assurance of Sterility

Tri-Coast Pharmacy D-0284-2017
Class II · Moderate risk Ongoing

Quad Mix

Reason Lack of Assurance of Sterility

Tri-Coast Pharmacy D-0283-2017
Class II · Moderate risk Ongoing

Quad Mix

Reason Lack of Assurance of Sterility

Tri-Coast Pharmacy D-0282-2017
Class II · Moderate risk Ongoing

Quad Mix

Reason Lack of Assurance of Sterility

Tri-Coast Pharmacy D-0281-2017
Class II · Moderate risk Ongoing

Quad Mix

Reason Lack of Assurance of Sterility

Tri-Coast Pharmacy D-0280-2017
Class III · Low risk Terminated

Olanzapine tablets

Reason Failed impurities/degradation specifications: due to out-of-specification result for the Related Substance Compound C (Impurity 6 - N-Oxide at the 18 month stability station.

Dr. Reddy's Laboratories, Inc. NDC 55111-163-30 D-0468-2017
Class III · Low risk Terminated

AHP NIFEdipine Capsules

Reason Presence of Foreign Tablets/Capsules

Amerisource Health Services D-0144-2017
Class III · Low risk Terminated

NIFEdipine Capsules USP

Reason Presence of Foreign Tablets/Capsules

Actavis Elizabeth LLC NDC 0228-2407-10 D-0143-2017
Class II · Moderate risk Terminated

Tri 2

Reason Lack of Assurance of Sterility

Wells Pharmacy Network LLC D-0408-2017
Class II · Moderate risk Terminated

Tri 1

Reason Lack of Assurance of Sterility

Wells Pharmacy Network LLC D-0407-2017
Class II · Moderate risk Terminated

Atropine Sulfate 0.01% in 0.9% Sodium Chloride

Reason Lack of Assurance of Sterility; all compounded products within expiry produced using recalled filters

Leiter's Compounding NDC 70360-011-39 D-0010-2017
Class II · Moderate risk Terminated

C-PAP/PHEN/PROST/Atrop 150/7.5

Reason Lack of Assurance of Sterility

Pharmacy Plus, Inc. dba Vital Care Compounder D-1547-2016
Class II · Moderate risk Terminated

C-Pap/Phen/Prost/Atrop 150/5/5

Reason Lack of Assurance of Sterility

Pharmacy Plus, Inc. dba Vital Care Compounder D-1545-2016
Class II · Moderate risk Terminated

ATROPINE SULFATE 0.5% Ophthalmic Drops

Reason Lack of Assurance of Sterility: FDA inspection identified GMP violations potentially impacting product quality and sterility.

Well Care Compounding Pharmacy D-0980-2016
Class II · Moderate risk Terminated

Norepinephrine Bitartrate 4 mg

Reason Lack of Assurance of Sterility

Pharmakon Pharmaceuticals, Inc. NDC 45183-0855-02 D-1311-2016